Prescribing
The NHS Cheshire and Merseyside Area Prescribing Group (APG) and its subgroups provide a framework to coordinate the integration of safe, clinically effective and cost-effective medicines across Cheshire and Merseyside. Improved outcomes and an improved experience for patients are central to the decision-making process.
The APG is a professional group consisting of GPs, pharmacists, and other key healthcare professionals who are responsible for ensuring robust standards and governance for decision-making.
-
Policies and Reports
APG policy, APG terms of reference, Conflicts of interest, RAG definitions, Free-of-charge schemes, Out-of-area requests, Fast-track process, and NICE TA adherence.
-
APG subgroups
New medicines, Formulary and guidelines, Interface prescribing, Safety, and Antimicrobial guide
-
Forms and applications
New service developments, individual funding requests, and appeals process
-
Publications
APG approvals report
-
Wegovy™ access in Cheshire and Merseyside
Wegovy® (Semaglutide) – a weight-management treatment – is currently only available to NHS patients via specialist Tier 3 or 4 weight management services.
-
Valproate
New regulatory measures for oversight of prescribing to new patients and existing female patients
Contact
For medicines optimisation enquiries, please email: Mop-enquiries@cheshireandmerseyside.nhs.uk